Framework for Equitable Allocation of COVID-19 Vaccine
By: Benjamin Kahn, Lisa Brown, William Foege, and Helene Gayle
Source: National Academies of Sciences, Engineering, and Medicine
Approval, allocation, and distribution of one or more safe and effective coronavirus disease 2019 (COVID-19) vaccines will be a remarkable achievement. However, as has been pointed out repeatedly since the earliest days of the COVID-19 pandemic, readying a vaccine is just the starting point of what will be a challenging journey to achieving widespread public acceptance of COVID-19 vaccines. Strong demand for and acceptance of COVID-19 vaccines will be critical for protecting vulnerable populations and for regaining our pre-pandemic social and economic lives, but ensuring demand and promoting acceptance will be challenging.
VARN2023 Conference Report (French)
Quand les communautés dirigent, l’immunisation mondiale réussit
VARN2023 Conference Report
Findings and insights from the Sabin Vaccine Institute’s VARN2023 conference
VARN2022: Shaping Global Vaccine Acceptance with Localized [Peer-Reviewed] Knowledge
Some of the most relevant findings are now available through the VARN2022 Supplement via BMC Proceedings...
Community-led Strategies to Aid Vaccine Acceptance: Nine Case Studies from Around the World
These case-study reports inform action and investment around the globe that seek to build more vaccine confident communities.
